GLP-1 Cardiovascular
Explore peptide research and guides on glp-1 cardiovascular.
GLP-1 Cardiovascular
Do GLP-1 Agonists Lower Blood Pressure?
GLP-1 agonists reduce systolic blood pressure by 2-5 mmHg on average. Here is what meta-analyses, CVOTs, and mechanistic research reveal.
GLP-1 CardiovascularGLP-1 Agonists and Atherosclerosis
GLP-1 receptor agonists reduce atherosclerotic cardiovascular events by 12-26% in major trials. Here is how they protect arteries at the cellular level.
GLP-1 CardiovascularGLP-1 Drugs and Heart Disease: Cardiovascular Trials
Seven major trials tested GLP-1 drugs for heart protection. What LEADER, SUSTAIN-6, SELECT, and other CVOTs found about heart attacks, strokes, and death.
GLP-1 CardiovascularHow GLP-1 Drugs Reduce Cardiovascular Inflammation
GLP-1 receptor agonists lower cardiovascular inflammation via NF-kB suppression, macrophage modulation, and epicardial fat changes. Here's the evidence.